A B S T R A C T Human lymphocytes from normal peripheral blood, thymus, spleen, thoracic duct, and peripheral lymphocytes from patients with chronic lymphatic leukemia were studied for complement receptor sites (CRL), surface immunoglobulin (SIg), and for the ability to form rosettes with sheep erythrocytes (TRFC). The two B cell markers (CRL and SIg) were found to be in overlapping, but not totally identical populations, whereas cells that were able to form rosettes were found in a totally unrelated population of lymphocytes; TRFC is therefore probably a reliable marker for T cells. In peripheral blood 24% of lymphocytes had SIg, but only half of these were also CRL. Almost all of the non-SIg peripheral blood lymphocytes were TRFC. In the spleen and thoracic duct only a few lymphocytes were observed that had SIg and were not CRL. On the other hand, in two of three spleens studied 10-20% of cells were CRL that did not have SIg. In the thoracic duct all non-CRL, non-SIg cells were TRFC. In chronic lymphatic leukemia three findings were made: (a) The presence or absence of CRL was independent of the presence or absence of SIg so that in individuals whose cells were non-SIg, CRL were usually plentiful. 
INTRODUCTION
Lymphocytes active in the immune response are derived from either the bone marrow (B cells) ' or from the thymus (T cells). Since each of these two types of lymphocytes has both independent and cooperative roles in the immune response, it is essential to be able to identify them easily in order to understand their overall function. The majority of B cells have easily de- tectable membrane-bound immunoglobulin on their surface, while T cells do not (1) (2) (3) . Most B cells also have a receptor for complement and are termed complement receptor lymphocytes or CRL (4, 5) . While studies of each of these two B cell markers have shown that neither is found on T cells, there is some doubt as to whether all B cells have both markers. In the mouse, T cells have the theta antigen and B cells do not. Human T cells can be identified by their lack of B cell markers and by their ability to form rosettes with sheep erythrocytes (6) (7) (8) .
The purpose of the present study was threefold: (a) to try to determine whether surface immunoglobulin (SIg) and the complement receptor were both present on the same lymphocytes in normal individuals, (b) to study the ability of human lymphocytes to form rosettes with sheep erythrocytes and determine whether only T cells have this property, and (c) to study lymphocytes from patients with chronic lymphatic leukemia (CLL) in order to determine whether these cells more closely resembled B or T cells. Special emphasis was placed on examining those leukemia patients whose cells did not have immunoglobulin detectable by imnlunofluorescence.
METHODS
Lymphocytes. Blood from normal adults and patients with a confirmed diagnosis of CLL was collected in heparin. Among the CLL patients, lymphocyte counts ranged from 25,000 to usually greater than 100,000 per mm8, and therefore, presumably the vast majority of the lymphocytes were leukemic. Thymus and spleen cells were obtained from autopsies of individuals known to have no gross immunological defect. Thoracic duct lymphocytes (TDL) were a generous gift from Dr. Joan Stratton and Dr. James B. Peter, and were obtained by continuous drainage of thoracic duct lymph from patients with severe rheumatoid arthritis and other collagen vascular diseases.
Separation of lymphocytes. Heparinized blood was diluted 1: 2 with 3% dextran T-250 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) in 0.0027 M EDTA-HBSS= (see abbreviation list) and allowed to sediment for 40 min at room temperature. The leukocyte-rich supernate was diluted to 3 times the original blood volume with 0.0027 M EDTA-HBSS= and 20 ml was layered onto 5 ml of ice-cold Hypaque-Ficoll (9, ' in siliconized 23-X 105-mm glass centrifuge tubes. These were centrifuged at 4°C for 20 min at 500 g. A layer consisting of 75-85% lymphocytes was aspirated from the interface. After two washes in 0.0027 M EDTA-HBSS=, the cells were resuspended at 2 X 106 leukocytes/ml in 30% fetal calf serum (FCS) in RPMI-1640 medium (Microbiological Associates, Inc., Bethesda, Md.) 2 Hypaque was substituted for isopaque (triosil) in the same ratio as previously described (9) .
containing 50 U/ml of penicillin and 50 jug/ml of streptomycin. These cells were poured into 100-X 20-mm plastic petri dishes, 10 (11) . Since 1.0 ml of a 1: 180 dilution of this antibody per 109 E was found to be optimal for hemolysis by guinea pig complement, a 1:120 dilution was used routinely.
Erythrocyte-antibody-complement complexes (EAC). EACl-9mo was prepared by mixing equal volumes of 2 X 108/ ml EA19s and normal mouse complement diluted 1: 5 or 1: 2.5 in gelatin veronal buffer with 0.15 mM CaCI2 and 0.5 mM MgCl2 (GVB). In order to produce EAC1-3mo, normal mouse complement was substituted by serum from a mouse known to be deficient in C5. Both mixtures were incubated at 370C for 30 min, then washed 3 times in icecold GVB and stored at 20C. The EAC1-9mo were used for not more than 2 days and the EAC1-3mo for up to 4 days. Normal mouse complement was obtained from CF1 male mice and C5-deficient mouse complement from AKR male mice. Mice were bled from the tail directly into a glass tube in an ice bath. After allowing the blood to clot for 3 h in the cold, the complement (serum) was separated by centrifugation and stored at -700C.
EAC14OxY23hu cells were prepared as previously described (12), the only difference being that oxidized C2 (13, 14) was substituted for native C2. The source of C4 was either highly purified C4 or fresh human serum heated at 560C for 30 min. EAC140x72 were formed from EAC14 by addition of 90 effective molecules of highly purified oxidized C2 (OXYC2) per cell, followed by reaction at 320C for 13 min and 2 washes with ice-cold GVB. EAC140xY23 were formed by addition of 100-150 lug C3 (15) [0
(L. S., H. C., and T. H.), whereas in the remaining cases, 41-85% of the lymphocytes were CRL using EACmo, a 3-7 times higher incidence than observed with normal peripheral blood lymphocytes (Table I) . TRFC in peripheral blood and thoracic duct. In the assay of TRFC it was important to resuspend the pellet by very gentle shaking of the tube. If (Table IV) ; however, since there were some B cells with only one of the two B surface markers, the total B cells had to be calculated from the percent of nonoverlap observed in the simultaneous assay of CRL and SIg: In contrast to the findings of Jondal, Holm, and Wigzell (8) , no inhibition of rosette formation was observed by treating both the lymphocytes and sheep E with EDTA (0.04 M EDTA-HBSS=, pH 7.2, isotonic, at 37°C for 30 min before mixing the cells and also during the assay) and therefore involvement of divalent cations in rosette formation is considered doubtful. Also, when EAC were substituted for sheep E, so that both CRL+ and TRFC+ cells could be as- (18) that it was necessary to incubate the lymphocytes at 37°C before pelleting them and incubating them at 0C. In addition, it was found that both the lymphocytes and sheep E must be prewarmed at 370C, but that they could be incubated at 37°C separately, cooled to 0°C, then mixed and pelleted. Contact of the sheep E and lymphocytes during the 370C incubation was therefore not obligatory for TRFC rosette formation. It was also found that in addition to sheep E, both dog E and goat E would form rosettes with TRFC but to a lesser extent than sheep E, 50% of TRFC detected with dog E and 25% of TRFC with goat E. TRFC in CLL. In order to further characterize the CLL patients with low percentages of SIg' cells (< 1-12%), studies of their capacities to form rosettes with sheep E were also done. One of these CLL patients (T. H.) also had a low percentage of CRL and therefore this patient's leukemia could have been of T cell origin. However, all three of these patients had only 3% of TRFC' cells (Table IV) as compared to 69-75% for normal individuals.
DISCUSSION
In the mouse, T and B cells can be distinguished by means of antilymphocyte sera, of either allogenic or xenogenic origin, which detect surface antigens (such as theta) on the T cell population which are not present on B cells. These differentiation antigens, however, have been shown to differ with regard to the amount of antigen present within populations of T cells, depending upon the origin of T cells; i.e., within the thymus or in peripheral organs (19) . In the B cell population four other surface markers have been described: (a) SIg detectable by immunofluorescence and similar techniques; (b) a complement receptor for the third component of complement; (c) a receptor for the Fc fragment of IgG (20)); and (d) surface antigens (such as MBLA) found on B cells and not T cells. As yet, no clear-cut antigenic markers have been described in the human to allow a distinction between T and B cells.
In an effort to describe the B and T lymphocyte populations in humans, SIg and the complement receptor have been used to identify B cells and the recently described sheep E rosette-forming capacity used to identify T cells (6) (7) (8) . Lymphocytes from normal individuals and individuals with CLL were studied. In human peripheral blood as much as 50% of lymphocytes that are SIg' are CRL-. In contrast in the spleen there appear to be some cells that are CRL' and SIg-(10-20%). In agreement with this we have found in mouse peripheral blood 14-20% of lymphocytes are SIg', whereas only 7-11% are CRL'. (Ross, G. D., and E. M. . Unpublished observation). There may also be a small population (5-10%) of B cells that are SIg-in the mouse. (Vassalli, P. 1972. Personal communication). Thus, at the present time in the human, as well as in the mouse, it would appear that neither CRL nor SIg is an altogether reliable marker for B cells. The situation appears to be quite analogous to that described for differentiation antigens, in that at different stages of differentiation and in different lymphocyte populations, more or less of these antigens may be present on the surface of cells and, depending upon the detection system, may or may not be detectable. Pincus, Bianco, and Nussenzwig (21) and Shevach, Herberman, Frank, and Green (22) have recently reported similar numbers of CRL in human peripheral blood as we observed. Jondal et al. (8) , on the other hand, reported nearly twice as many CRL in peripheral blood, with nearly equal numbers of CRL and SIg cells. In our combined simultaneous study of both markers on the same cells, we always found that 50% or more of the fluorescent (SIg') lymphocytes from peripheral blood were CRL-. Jondal et al. (8) assayed CRL and SIg separately, and therefore could not have seen the significant numbers of SIg' CRL-lymphocytes that we observed. All of our data given in Table I (26) . Fur- thermore, in freeze-thaw lysates containing the total surface and cytoplasmic immunoglobulin, it was demonstrated that similar amounts of immunoglobulin were associated with the cells that lacked detectable SIg by immunofluorescence, as compared to those which contained it. Also, these amounts of immunoglobulin are only slightly less than those found in normal B cells and are much larger than any amount of immunoglobulin which has been previously (letecte(l in T cell populations (26, 27) .
The second finding to emerge from the study of CRL in CLL was that the leukemic cells reacted weakly with human C3 compared to mouse C3. This was in sharp contrast to normal human peripheral blood lymphocytes with which fairly similar data were obtained with the two sources of complement, human complement detecting slightly more CRL than mouse complement. \With CLL, mouse complement detected equal numbers (2 out of 10 patients) or considerably larger numbers of CRL (8 out of 10 patients) than did human complement. The reason for this discrepancy between leukemic and normal lymphocytes is at present totally unknown, but it is suggestive that an altered complement receptor may be present on the leukemic cells. Furthermore, our data demonstrate that patients with low SIg do not contain appreciable amounts of TRFC. These data are similar to those obtained by others who studied TRFC in CLL patients with a high percentage of SIg' cells (7, 8) .
Previously, four other studies of CRL in CLL had been reported (21, 22, 28, 29 Recently several investigators have reported that human T lymphocytes form rosettes with sheep erythrocytes. In the early studies only a relatively small population of peripheral blood lymphocytes formed rosettes (6, 7, 18, 30) ; however, with some modifications in the technique, the studies of Jondal et al. (8) as well as our own clearly indicate that the reaction between sheep erythrocytes and human lymphocytes is a quantitative marker for T cells and that in combination with markers for B cells such as SIg and CRL, all the lymphocytes in normal peripheral blood and thoracic duct can be accounted for.
